Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SHS NEW
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
1.9M
-
Shares change
-
+1.89M
-
Total reported value, excl. options
-
$40.2M
-
Value change
-
+$40M
-
Number of buys
-
13
-
Price
-
$21.21
Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q2 2021
14 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q2 2021.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.9M shares
.
Largest 10 shareholders include Roumell Asset Management, LLC (563K shares), INVESTMENT MANAGEMENT OF VIRGINIA LLC (530K shares), VILLERE ST DENIS J & CO LLC (247K shares), FRIESS ASSOCIATES LLC (235K shares), STATE STREET CORP (176K shares), BENJAMIN F. EDWARDS & COMPANY, INC. (64.6K shares), Weil Company, Inc. (30.5K shares), RAYMOND JAMES & ASSOCIATES (20.8K shares), CITADEL ADVISORS LLC (13K shares), and ACT Capital Management, LLC (7.5K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.